Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Rybak

Showing results (91-100 of 531) with videos related to

Pageof 54
Sort By:
Reumatologia|January 1, 1975
[Therapeutic rehabilitation of children with rheumatoid arthritis complicated by amyloidosis]K Rostropowicz-Denisiewicz, A Romicka, J Rybak
Advanced Drug Delivery Reviews|June 15, 2011
Complement activation by carbon nanotubesMalgorzata J Rybak-Smith, Robert B Sim
The American Journal of Gastroenterology|August 1, 1978
Cystosarcoma phyllodes metastatic to the pancreasP Wolfson, B J Rybak, U Kim
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 9, 2022
Panacea or oversimplification: Relating AUC and troughsNicholas Rebold, Thomas Lodise, Michael J Rybak
The Lancet. Infectious Diseases|October 26, 2023
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistrySara Alosaimy, Michael J Rybak, George Sakoulas
Infectious Diseases and Therapy|October 5, 2018
Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant OrganismsSarah C J Jorgensen, Michael J Rybak
Antimicrobial Agents and Chemotherapy|April 19, 2000
Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelJ R Aeschlimann, E Hershberger, M J Rybak
The Annals of Pharmacotherapy|January 1, 1992
Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patientsW R Melchior, V Bindlish, M J Rybak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 1996
Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapyB Mitrzyk, P E Jarco, M J Rybak
Antimicrobial Agents and Chemotherapy|August 3, 1999
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureusJ R Aeschlimann, E Hershberger, M J Rybak
Pageof 54

Showing results (91-100 of 531) with videos related to

Sort By:
Pageof 54
Reumatologia|January 1, 1975
[Therapeutic rehabilitation of children with rheumatoid arthritis complicated by amyloidosis]K Rostropowicz-Denisiewicz, A Romicka, J Rybak
Advanced Drug Delivery Reviews|June 15, 2011
Complement activation by carbon nanotubesMalgorzata J Rybak-Smith, Robert B Sim
The American Journal of Gastroenterology|August 1, 1978
Cystosarcoma phyllodes metastatic to the pancreasP Wolfson, B J Rybak, U Kim
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|February 9, 2022
Panacea or oversimplification: Relating AUC and troughsNicholas Rebold, Thomas Lodise, Michael J Rybak
The Lancet. Infectious Diseases|October 26, 2023
Understanding vancomycin nephrotoxicity augmented by β-lactams: a synthesis of endosymbiosis, proximal renal tubule mitochondrial metabolism, and β-lactam chemistrySara Alosaimy, Michael J Rybak, George Sakoulas
Infectious Diseases and Therapy|October 5, 2018
Pathogen-Specific Clinical Trials: A New Paradigm in Clinical Trials for Multidrug-Resistant OrganismsSarah C J Jorgensen, Michael J Rybak
Antimicrobial Agents and Chemotherapy|April 19, 2000
Activities of trovafloxacin and ampicillin-sulbactam alone or in combination versus three strains of vancomycin- intermediate Staphylococcus aureus in an in vitro pharmacodynamic infection modelJ R Aeschlimann, E Hershberger, M J Rybak
The Annals of Pharmacotherapy|January 1, 1992
Intravitreal ganciclovir for cytomegalovirus retinitis in AIDS patientsW R Melchior, V Bindlish, M J Rybak
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|December 1, 1996
Stability and antimicrobial activity of gentamicin sulfate, tobramycin sulfate and amikacin sulfate in polypropylene syringes for use in once-daily aminoglycoside therapyB Mitrzyk, P E Jarco, M J Rybak
Antimicrobial Agents and Chemotherapy|August 3, 1999
Analysis of vancomycin population susceptibility profiles, killing activity, and postantibiotic effect against vancomycin-intermediate Staphylococcus aureusJ R Aeschlimann, E Hershberger, M J Rybak
Pageof 54